Comparison of HIV prevalence, incidence, and viral load suppression in Zambia population-based HIV impact assessments from 2016 and 2021
- PMID: 38227572
- PMCID: PMC11402832
- DOI: 10.1097/QAD.0000000000003834
Comparison of HIV prevalence, incidence, and viral load suppression in Zambia population-based HIV impact assessments from 2016 and 2021
Abstract
Background: The Zambian government has implemented a public health response to control the HIV epidemic in the country. Zambia conducted a population-based HIV impact assessment (ZAMPHIA) survey in 2021 to assess the status of the HIV epidemic to guide its public health programs.
Methods: ZAMPHIA 2021 was a cross-sectional two-stage cluster sample household survey among persons aged ≥15 years conducted in Zambia across all 10 provinces. Consenting participants were administered a standardized questionnaire and whole blood was tested for HIV according to national guidelines. HIV-1 viral load (VL), recent HIV infection, and antiretroviral medications were tested for in HIV-seropositive samples. Viral load suppression (VLS) was defined as <1000 copies/ml. ZAMPHIA 2021 results were compared to ZAMPHIA 2016 for persons aged 15-59 years (i.e., the overlapping age ranges). All estimates were weighted to account for nonresponse and survey design.
Results: During ZAMPHIA 2021, of 25 483 eligible persons aged ≥15 years, 18 804 (73.8%) were interviewed and tested for HIV. HIV prevalence was 11.0% and VLS prevalence was 86.2% overall, but was <80% among people living with HIV aged 15-24 years and in certain provinces. Among persons aged 15-59 years, from 2016 to 2021, HIV incidence declined from 0.6% to 0.3% ( P -value: 0.07) and VLS prevalence increased from 59.2% to 85.7% ( P -value: <0.01).
Discussion: Zambia has made substantial progress toward controlling the HIV epidemic from 2016 to 2021. Continued implementation of a test-and-treat strategy, with attention to groups with lower VLS in the ZAMPHIA 2021, could support reductions in HIV incidence and improve overall VLS in Zambia.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest
There are no conflicts of interest.
Figures
Similar articles
-
Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.J Int AIDS Soc. 2020 Nov;23(11):e25631. doi: 10.1002/jia2.25631. J Int AIDS Soc. 2020. PMID: 33225559 Free PMC article.
-
Population Viral Load, Viremia, and Recent HIV-1 Infections: Findings From Population-Based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and Zambia.J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S81-S88. doi: 10.1097/QAI.0000000000002637. J Acquir Immune Defic Syndr. 2021. PMID: 33560041 Free PMC article.
-
Prevalence and correlates of active syphilis and HIV co-Infection among sexually active persons aged 15-59 years in Zambia: Results from the Zambia Population-based HIV Impact Assessment (ZAMPHIA) 2016.PLoS One. 2020 Jul 24;15(7):e0236501. doi: 10.1371/journal.pone.0236501. eCollection 2020. PLoS One. 2020. PMID: 32706823 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Same-day ART initiation, loss to follow-up and viral load suppression among people living with HIV in low- and middle-income countries: systematic review and meta-analysis.Pan Afr Med J. 2023 Nov 27;46:92. doi: 10.11604/pamj.2023.46.92.40848. eCollection 2023. Pan Afr Med J. 2023. PMID: 38405092 Free PMC article.
Cited by
-
The impact of the SKILLZ intervention on sexual and reproductive health empowerment among Zambian adolescent girls and young women: results of a cluster randomized controlled trial.Reprod Health. 2025 Jun 5;22(1):95. doi: 10.1186/s12978-025-02046-6. Reprod Health. 2025. PMID: 40474217 Free PMC article.
References
-
- The World Bank. Life expectancy at birth, total (years) – Zambia. Available at: https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=ZM [cited 2023 Jun 1].
-
- World Health; Organization (WHO). Guideline on when to start antiretroviral therapy and on preexposure prophylaxis for HIV. Geneva, Switzerland; 2015. Available at: https://www.who.int/publications/i/item/9789241509565. - PubMed
-
- World Health Organization (WHO). Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva, Switzerland; 2017. Available at: https://www.who.int/publications/i/item/9789241550062. - PubMed
-
- Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, et al. Dolutegravir plus Abacavir-Lamivudine for the Treatment of HIV-1 Infection. N EnglJ Med 2013; 369:1807–1818. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical